Raymond James analyst Danielle Brill reinstates Sage Therapeutics (NASDAQ:SAGE) with a Market Perform.
Raymond James Reinstates Market Perform on Sage Therapeutics
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.